Pharmaceutical Research and Manufacturers of America (PHRMA)

trade group representing U.S. pharmaceutical research and biotechnology companies

Based in DC

🤖

AI Overview

With $1.4M in lobbying spend across 29 quarterly filings, Pharmaceutical Research and Manufacturers of America (PHRMA) is a significant lobbying presence.

$1.4M
Total Lobbying Spend
29
Quarterly Filings
1
Lobbying Firms Used
1
Individual Lobbyists

Spending by Year

YearLobbying Spend
2018$240K
2019$180K
2020$240K
2021$150K
2022$160K
2023$160K
2024$120K
2025$100K

Lobbying Firms

DESIMONE CONSULTING, LLC

What They Lobby For

  • Issues related to the impact of the bio-pharmaceutical industry on the economy.
  • Issues related to policy changes to Medicare Part B & D.
  • Issues related to intellectual property protections in foreign trade agreements.
  • Issues related to the development of new medical therapies.
  • Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the biopharmaceutical industry.
  • Issues related to the development of new medical therapies including patient access and pricing; H.R.6201, Families First Coronavirus Response Act (P.L.116-127); H.R.748, CARES Act (P.L.116-136).
  • Issues related to the impact of the bio-pharmaceutical industry on the economy; H.R.748, CARES Act (P.L.116-136).
  • Issues related to access to medicines and other medical therapies, the development of new medical therapies, pharmaceutical supply chain and regulatory matters regarding the biopharmaceutical industry.
  • Issues related to the development of new medical therapies including patient access and pricing.
  • Issues related to policy changes to Medicare Part D.

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.